Author:
Zangani Caroline,Ostinelli Edoardo Giuseppe,Giordano Barbara,D’Agostino Armando,Martinotti Giovanni,Clerici Massimo,Gambini Orsola,Schifano Fabrizio
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference64 articles.
1. Abdulrahim, D., & Bowden-Jones, O. (2015). Guidance on the management of acute and chronic harms of club drugs and novel psychoactive substances. Novel Psychoactive Treatment UK Network (NEPTUNE).
2. Andrade, A. G., Duarte, P., Barroso, L. P., Nishimura, R., Alberghini, D. G., & Oliveira, L. G. (2012). Use of alcohol and other drugs among Brazilian college students: Effects of gender and age. Revista brasileira de psiquiatria (Sao Paulo, Brazil: 1999), 34(3), 294–305.
3. Anzillotti, L., Calò, L., Banchini, A., Schirripa, M. L., Marezza, F., & Cecchi, R. (2020). Mephedrone and chemsex: A case report. Legal Medicine, 42, 101640. https://doi.org/10.1016/j.legalmed.2019.101640
4. Assi, S., Gulyamova, N., Ibrahim, K., Kneler, P., & Osselton, D. (2017). Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies. Human Psychopharmacology: Clinical and Experimental, 32, e2607. https://doi.org/10.1002/hup2607
5. Benschop, A., Urbán, R., Kapitány-Fövény, M., et al. (2020). Why do people use new psychoactive substances? Development of a new measurement tool in six European countries. Journal of Psychopharmacology, 34(6), 600–611. https://doi.org/10.1177/0269881120904951